Search research articles
Contact Us
Filters
Showing results (81-90 of 279) with videos related to
Page
of 28
Sort By:
JAMA Neurology
|
March 29, 2016
Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease
Rawan Tarawneh, Gina D'Angelo, Dan Crimmins, et al.
Plos One
|
May 24, 2013
Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation
Richard J Perrin, Jacqueline E Payton, James P Malone, et al.
EMBO Molecular Medicine
|
January 6, 2010
Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease
Anne M Fagan, Mark A Mintun, Aarti R Shah, et al.
Archives of Neurology
|
September 14, 2011
Cerebrospinal fluid biomarkers, education, brain volume, and future cognition
Catherine M Roe, Anne M Fagan, Elizabeth A Grant, et al.
Frontiers in Neuroscience
|
May 2, 2022
Plasma Neurofilament Light Chain Levels Are Elevated in Children and Young Adults With Wolfram Syndrome
Sarah A Eisenstein, Raveena S Boodram, Courtney L Sutphen, et al.
Neurobiology of Disease
|
February 15, 2022
Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage
Karin L Meeker, Omar H Butt, Brian A Gordon, et al.
Journal of Alzheimer'S Disease : JAD
|
July 17, 2010
Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels
John S K Kauwe, Carlos Cruchaga, Sarah Bertelsen, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
July 19, 2016
Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels
Ganesh M Babulal, Nupur Ghoshal, Denise Head, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 6, 2019
Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease
Isabelle Bos, Stephanie J B Vos, Suzanne E Schindler, et al.
Science Translational Medicine
|
December 16, 2016
Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury
Marc Suárez-Calvet, Miguel Ángel Araque Caballero, Gernot Kleinberger, et al.
Page
of 28
Search research articles
Search
Showing results (81-90 of 279) with videos related to
Sort By:
Page
of 28
JAMA Neurology
|
March 29, 2016
Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease
Rawan Tarawneh, Gina D'Angelo, Dan Crimmins, et al.
Plos One
|
May 24, 2013
Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation
Richard J Perrin, Jacqueline E Payton, James P Malone, et al.
EMBO Molecular Medicine
|
January 6, 2010
Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease
Anne M Fagan, Mark A Mintun, Aarti R Shah, et al.
Archives of Neurology
|
September 14, 2011
Cerebrospinal fluid biomarkers, education, brain volume, and future cognition
Catherine M Roe, Anne M Fagan, Elizabeth A Grant, et al.
Frontiers in Neuroscience
|
May 2, 2022
Plasma Neurofilament Light Chain Levels Are Elevated in Children and Young Adults With Wolfram Syndrome
Sarah A Eisenstein, Raveena S Boodram, Courtney L Sutphen, et al.
Neurobiology of Disease
|
February 15, 2022
Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage
Karin L Meeker, Omar H Butt, Brian A Gordon, et al.
Journal of Alzheimer'S Disease : JAD
|
July 17, 2010
Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels
John S K Kauwe, Carlos Cruchaga, Sarah Bertelsen, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
July 19, 2016
Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels
Ganesh M Babulal, Nupur Ghoshal, Denise Head, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 6, 2019
Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease
Isabelle Bos, Stephanie J B Vos, Suzanne E Schindler, et al.
Science Translational Medicine
|
December 16, 2016
Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury
Marc Suárez-Calvet, Miguel Ángel Araque Caballero, Gernot Kleinberger, et al.
Page
of 28